[(Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. P8696W104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A ]
[Sinovac Holds 2017 Annual General Meeting of Shareholders BEIJING, February 7, 2018 / PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it held its 2017 Annual General Meeting of Shareholder]
[Sinovac Holds 2017 Annual General Meeting of Shareholders BEIJING, February 7, 2018 / PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it held its 2017 Annual General Meeting of Shareholder]
[______________ FORM 8-K ______________ CURRENT REPORT Date of Report (Date of earliest event reported): January 29, 2018 ______________ BIOSTAR PHARMACEUTICALS, INC. ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identificatio]
[Our ref.: PS/SC/B397/AUD3/pp February 2, 2018 100F Street NE Washington DC Dear Sirs, We have read Item 4.0l (a) of Biostar Pharmaceuticals, Inc's Form 8-K, which discusses the resignation of Mazars CPA Limited as its independent registered public accounting firm, and we agree with the statements ma]
[Our ref.: PS/SC/B397/AUD3/pp February 2, 2018 100F Street NE Washington DC Dear Sirs, We have read Item 4.0l (a) of Biostar Pharmaceuticals, Inc's Form 8-K, which discusses the resignation of Mazars CPA Limited as its independent registered public accounting firm, and we agree with the statements ma]
[Sinovac Biotech Ltd. , 2018 Shareholders of Sinovac Biotech Ltd. Re: Notice of Special Meeting of Shareholders Dear Shareholder: Company You are cordially invited to attend a special meeting of shareholders of Sinovac Biotech Ltd. (the “ Amalgamation Agreement Parent Amalgamation Sub Amalgamation Su]
[Sinovac Biotech Ltd. , 2018 Shareholders of Sinovac Biotech Ltd. Re: Notice of Special Meeting of Shareholders Dear Shareholder: Company You are cordially invited to attend a special meeting of shareholders of Sinovac Biotech Ltd. (the “ Amalgamation Agreement Parent Amalgamation Sub Amalgamation Su]
[Sinovac Biotech Ltd. , 2018 Shareholders of Sinovac Biotech Ltd. Re: Notice of Special Meeting of Shareholders Dear Shareholder: Company You are cordially invited to attend a special meeting of shareholders of Sinovac Biotech Ltd. (the “ Amalgamation Agreement Parent Amalgamation Sub Amalgamation Su]
[Sinovac Biotech Ltd. , 2018 Shareholders of Sinovac Biotech Ltd. Re: Notice of Special Meeting of Shareholders Dear Shareholder: Company You are cordially invited to attend a special meeting of shareholders of Sinovac Biotech Ltd. (the “ Amalgamation Agreement Parent Amalgamation Sub Amalgamation Su]
